Periodic safety reporting schedule
Active Substances | Trade Name | MAH | Year of registration in Saudi Arabia | International Birth Date (IBD) | PSUR Submission Frequency | Data Lock Point (DLP) | Submission Date |
---|---|---|---|---|---|---|---|
Irbesartan | APROVEL | SANOFI PASTEUR | 3 years | ||||
Irbesartan/HCTZ | CoAprovel | SANOFI PASTEUR | 3 years | ||||
Insulin aspart | NovoMix 70 Penfill | NOVO NORDISK | 3 years | ||||
Diclofenac (topical formulations) | diclofenac | GLAXOSMITHKLINE (GSK) | 3 years | ||||
Diclofenac Sodium | VOTREX | Hikma Pharmaceuticals PLC | 3 years | ||||
Diclofenac sodium | Emifenac 50 DT | SANOFI PASTEUR | 3 years | ||||
Insulin aspart | NovoRapid FlexPen | NOVO NORDISK | 3 years | ||||
Insulin aspart | NovoMix 50 FlexPen | NOVO NORDISK | 3 years | ||||
diclofenac (systemic formulations,injection) | VOTREX | Hikma Pharmaceuticals PLC | 3 years | ||||
Insulin aspart | NovoRapid Penfill | NOVO NORDISK | 3 years |